PROTOCOL REVIEW AND MONITORING SYSTEM (Core 012)
PROTOCOL REVIEW AND MONITORING SYSTEM (Core 012)
批准号:
8999048
负责人:
SYMA IQBAL
金额:
$7.89万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-12-01 至 2020-11-30
关键词:
AddressCatchment AreaCenter Core GrantsClinical ProtocolsCommunicationDisciplineEnrollmentFrequenciesGoalsMalignant NeoplasmsMissionMonitorOrganizational ChangePeer ReviewPoliciesProcessProtocols documentationReaction TimeResearch PersonnelResourcesSelection CriteriaStructureSystemTimeUSC/Norris Comprehensive Cancer Center and HospitalWritingabstractingclinical investigationimprovedinnovationmeetingsmemberquality assurance
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
The USC Norris Protocol Review and Monitoring System (PRMS) has two organizational components, the
Clinical Investigations Committee (CIC) and the Scientific Progress and Accrual Monitoring Subcommittee.
During the project period, PRMS has been significantly improved, resulting in reduced turnaround time and
fewer low accruing trials. Members of the CIC now represent a broad range of scientific disciplines and the
clear majority is senior investigators. To assure quality reviews, we have clarified member selection criteria and
term limit policies. We have also increased the frequency of CIC meetings and attendance rates, enhanced
scientific review and prioritization processes, improved written communications with PIs, and added maximum
PI response times to reduce delays. A new operational and financial review process has been added and
integrated into the PRMS workflow to assure operational feasibility without increasing turnaround. These and
other improvements have improved quality in the initial scientific review process and halved time to PRMS
approval, which averages four weeks. To enhance scientific monitoring of approved trials and to close trials
that are not achieving their enrollment targets more quickly, we formed a dedicated Scientific Progress and
Accrual Monitoring Subcommittee. The resulting structure completely separates scientific review and quality
assurance. With this organizational change, an existing accrual monitoring policy was tightened so that we can
close trials that are consuming institutional resources and are not enrolling at a reasonable pace. In summary,
the current PRMS process is highly effective in selecting and supporting investigator initiated trials and recent
changes having a very positive impact on both quality and efficiency. Additional improvements will be achieved
as OnCore is fully implemented and longer-term results are realized.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: PHASE I CLINICAL AND PHARMACOKINETIC TRIAL OF INTRAPERITONEAL IR
-
批准号:7982096
-
项目类别:
-
资助金额:$1.39万
-
财政年份:2008
-
负责人:SYMA IQBAL
-
依托单位:
PHII-51: A RANDOMIZED PHASE 2 NON-COMPARATIVE STUDY OF SB-715992 GIVEN WEEKLY
-
批准号:7368223
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2005
-
负责人:SYMA IQBAL
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10620219
-
项目类别:
-
资助金额:$15.96万
-
财政年份:1996
-
负责人:SYMA IQBAL
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10332413
-
项目类别:
-
资助金额:$16.09万
-
财政年份:1996
-
负责人:SYMA IQBAL
-
依托单位:
PROTOCOL REVIEW AND MONITORING SYSTEM (Core 012)
-
批准号:9359377
-
项目类别:
-
资助金额:$13.77万
-
财政年份:--
-
负责人:SYMA IQBAL
-
依托单位:
海外基金